Back to results
US 2026/0092054 A1Published application
Fused ring compound and pharmaceutical containing same
AssigneeKaken Pharmaceutical Co., Ltd.
InventorsYoshitake SUMIKAWA, Issei AKAHOSHI, Masaya KATO
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel compound that has STAT6 inhibitory activity and is effective for treatment of inflammatory diseases such as atopic dermatitis and for allergic diseases. A compound pharmaceutically acceptable salt thereof expressed by general formula (I) having STAT6 inhibitory activity.
Claims26
A compound of formula (I):
- wherein
- X1 is CH, X2 is CH, and X4 is CH;
- R1 is an optionally substituted 5-membered heteroaryl group, an optionally substituted 5- to 6-membered non-aromatic heterocyclic group, an optionally substituted pyridonyl group, —C(═O)—NRaRb, or —NRc—C(═O)Rd, wherein Ra, Rb, Rc, and Rd each independently represents a hydrogen atom or a C1-C6 alkyl group;
- R2 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- or R1 and R2 together with the carbon atoms to which they are attached form an optionally substituted 5- to 6-membered non-aromatic heterocyclic group;
- R3 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- R4 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted C1-C3 alkoxy-C2-C6 alkyl group, an optionally substituted C1-C3 haloalkoxy-C2-C6 alkyl group, or an optionally substituted C3-C6 cycloalkyl-C1-C6 alkyl group;
- Q1 is C(═O) or CH2;
- Q2 is NH or O;
- X3 is N or CR6, wherein R6 is a hydrogen atom, a halogen atom, a cyano group, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted hydroxy-C1-C6 alkyl group, an optionally substituted cyano-C1-C6 alkyl group, an optionally substituted C3-C6 cycloalkyl group, an optionally substituted C1-C6 alkoxy-C1-C6 alkyl group, an optionally substituted C2-C6 alkenyl group, an optionally substituted C2-C6 alkynyl group, or an optionally substituted phenyl group;
- Y1 and Y2 are each independently N or CR7, wherein R7 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- and
- ring A is an optionally substituted phenyl group or an optionally substituted 5- to 6-membered heteroaryl group, wherein the phenyl group or the 5- to 6-membered heteroaryl group are optionally further fused with another ring to form an optionally substituted 8- to 10-membered fused ring;
- or a pharmaceutically acceptable salt thereof.
11 more elements
(canceled)
(canceled)
(canceled)
16-18. (canceled)
(canceled)
(canceled)
A compound of formula (I):
- wherein
- X1 is N, X2 is CH, and X4 is CH;
- R1 is an optionally substituted 5-membered heteroaryl group, an optionally substituted 5- to 6-membered non-aromatic heterocyclic group, an optionally substituted pyridonyl group, —C(═O)—NRaRb, or —NRc—C(═O)Rd, wherein Ra, Rb, Rc, and Rd each independently represents a hydrogen atom or a C1-C6 alkyl group;
- R2 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- or R1 and R2 together with the carbon atoms to which they are attached form an optionally substituted 5- to 6-membered non-aromatic heterocyclic group;
- R3 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- R4 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted C1-C3 alkoxy-C2-C6 alkyl group, an optionally substituted C1-C3 haloalkoxy-C2-C6 alkyl group, or an optionally substituted C3-C6 cycloalkyl-C1-C6 alkyl group;
- Q1 is C(═O) or CH2;
- Q2 is NH or O;
- X3 is N or CR6, wherein R6 is a hydrogen atom, a halogen atom, a cyano group, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted hydroxy-C1-C6 alkyl group, an optionally substituted cyano-C1-C6 alkyl group, an optionally substituted C3-C6 cycloalkyl group, an optionally substituted C1-C6 alkoxy-C1-C6 alkyl group, an optionally substituted C2-C6 alkenyl group, an optionally substituted C2-C6 alkynyl group, or an optionally substituted phenyl group;
- Y1 and Y2 are each independently N or CR7, wherein R7 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- and
- ring A is an optionally substituted phenyl group or an optionally substituted 5- to 6-membered heteroaryl group, wherein the phenyl group or the 5- to 6-membered heteroaryl group are optionally further fused with another ring to form an optionally substituted 8- to 10-membered fused ring;
- or a pharmaceutically acceptable salt thereof.
11 more elements
A compound of formula (I):
- wherein
- X1 is CH, X2 is CH, and X4 is N;
- R1 is an optionally substituted 5-membered heteroaryl group, an optionally substituted 5- to 6-membered non-aromatic heterocyclic group, an optionally substituted pyridonyl group, —C(═O)—NRaRb, or —NRc—C(═O)Rd, wherein Ra, Rb, Rc, and Rd each independently represents a hydrogen atom or a C1-C6 alkyl group;
- R2 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- or R1 and R2 together with the carbon atoms to which they are attached form an optionally substituted 5- to 6-membered non-aromatic heterocyclic group;
- R3 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- R4 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted C1-C3 alkoxy-C2-C6 alkyl group, an optionally substituted C1-C3 haloalkoxy-C2-C6 alkyl group, or an optionally substituted C3-C6 cycloalkyl-C1-C6 alkyl group;
- Q1 is C(═O) or CH2;
- Q2 is NH or O;
- X3 is N or CR6, wherein R6 is a hydrogen atom, a halogen atom, a cyano group, an optionally substituted C1-C6 alkyl group, an optionally substituted C1-C6 haloalkyl group, an optionally substituted hydroxy-C1-C6 alkyl group, an optionally substituted cyano-C1-C6 alkyl group, an optionally substituted C3-C6 cycloalkyl group, an optionally substituted C1-C6 alkoxy-C1-C6 alkyl group, an optionally substituted C2-C6 alkenyl group, an optionally substituted C2-C6 alkynyl group, or an optionally substituted phenyl group;
- Y1 and Y2 are each independently N or CR7, wherein R7 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted C1-C6 haloalkyl group;
- and
- ring A is an optionally substituted phenyl group or an optionally substituted 5- to 6-membered heteroaryl group, wherein the phenyl group or the 5- to 6-membered heteroaryl group are optionally further fused with another ring to form an optionally substituted 8- to 10-membered fused ring;
- or a pharmaceutically acceptable salt thereof.
11 more elements
Dependencies are inferred from the claim text.